Why is Artemis Medicare falling/rising?

As of 29-Aug, Artemis Medicare Services Ltd is experiencing a decline in its stock price, currently at Rs 218.80, reflecting a decrease of Rs 5.4 or 2.41%. The stock has underperformed its sector by 1.79% today and is trading lower than all its moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 4.59% away from Rs 208.75. Over the past week, the stock has fallen by 8.53%, and its year-to-date performance shows a significant decline of 30.30%. While the company has reported healthy long-term growth with a 49.66% annual increase in operating profit and consistent positive results over the last six quarters, the stock's return over the past year is notably negative at -18.18%, despite a 55.8% increase in profits.
In the broader market context, the Sensex has only declined by 1.84% over the past week, highlighting that Artemis Medicare's performance is significantly worse than the market average. The company's low return on equity of 8.11% and the fact that 44.53% of promoter shares are pledged contribute to investor concerns, further pressuring the stock price downward. The falling investor participation, with a 5.92% decrease in delivery volume, also suggests a lack of confidence among shareholders. Overall, while the company shows potential for growth, the combination of poor management efficiency, high pledged shares, and underperformance relative to the market has led to the stock's current decline.